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The growing incidence of global lung cancer cases against successful treatment modalities has 
increased the demand for the development of innovative strategies to complement conventional 
chemotherapy, radiation, and surgery. The substitution of chemotherapeutics by naturally 
occurring phenolic compounds has been touted as a promising research endeavor, as they 
sideline the side effects of current chemotherapy drugs. However, the therapeutic efficacy of 
these compounds is conventionally lower than that of chemotherapeutic agents due to their 
lower solubility and consequently poor intracellular uptake. Therefore, we report herein a 
hydrophobically modified chitosan nanoparticle (pCNP) system for the encapsulation of 
protocatechuic acid (PCA), a naturally occurring but poorly soluble phenolic compound, for 
increased efficacy and improved intracellular uptake in A549 lung cancer cells. The pCNP 
system was modified by the inclusion of a palmitoyl group and physico-chemically 
characterized to assess its particle size, Polydispersity Index (PDI) value, amine group 
quantification, functional group profiling, and morphological properties. The inclusion of 
hydrophobic palmitoyl in pCNP-PCA was found to increase the encapsulation of PCA by 
54.5% compared to unmodified CNP-PCA samples whilst it only conferred a 23.4% larger 
particle size. The single-spherical like particles with uniformed dispersity pCNP-PCA 
exhibited IR bands, suggesting the successful incorporation of PCA within its core, and a 
hydrophobic layer was elucidated via electron micrographs. The cytotoxic efficacy was then 
assessed by using an MTT cytotoxicity assay towards A549 human lung cancer cell line and 
was compared with traditional chitosan nanoparticle system. Fascinatingly, a controlled release 
delivery and enhanced therapeutic efficacy were observed in pCNP-PCA compared to CNP, 
which is ascribed to lower IC50 values in the 72-h treatment in the pCNP system. Using the 
hydrophobic system, efficacy of PCA was significantly increased in 24-, 48-, and 72-h 
treatments compared to a single administration of the compound, and via the unmodified CNP 
system. Findings arising from this study exhibit the potential of using such modified 
nanoparticulate systems in increasing the efficacy of natural phenolic compounds by 
augmenting their delivery potential for better anti-cancer responses. 
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